Tuesday, June 22, 2010
© Copyright 2013
Gwinnett Daily Post
LAWRENCEVILLE — Gwinnett Medical Center will reopen an acute stroke clinical research study, delving into the potential for treatment over a longer period of time.
Atlanta-based Dr. Marshall L. Nash, the director of stroke and neuroscience research at GMC and CEO of neurostudies.net, is a leading enroller of patients in clinical research studies investigating potential treatment options of stroke where there are no alternatives available. The only FDA-approved treatment for acute stroke must be given within a few hours after the onset of stroke symptoms. The study will explore the possibility of effective treatment for up to 24 hours after the onset of symptoms. “A large part of my clinical research practice at neurostudies.net and Gwinnett Medical Center is conducting cutting edge research for diseases with no viable treatment option,” Nash said. For more information, visit neurostudies.net.More like this story
- GMC receives award for stroke patient care ( February 26, 2013 )
- Chest pain center's accreditation gets renewed ( January 18, 2011 )
- Nuns leaving brains to science<br/> Part of long-running Alzheimer's study ( December 26, 2007 )
- GMC named to quality honor roll ( February 22, 2011 )
- Gwinnett Medical Center awarded for stroke care ( July 18, 2007 )
Comments
Use the comment form below to begin a discussion about this content.
Sign in to comment
Or login with:
OpenID